CoChat

SINE transcription by RNA polymerase III is suppressed by histone methylation but not by DNA methylation

Open access

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Short interspersed nuclear elements (SINEs), such as Alu, spread by retrotransposition, which requires their transcripts to be copied into DNA and then inserted into new chromosomal sites. This can lead to genetic damage through insertional mutagenesis and chromosomal rearrangements between non-allelic SINEs at distinct loci. SINE DNA is heavily methylated and this was thought to suppress its accessibility and transcription, thereby protecting against retrotransposition. Here we provide several lines of evidence that methylated SINE DNA is occupied by RNA polymerase III, including the use of high-throughput bisulphite sequencing of ChIP DNA. We find that loss of DNA methylation has little effect on accessibility of SINEs to transcription machinery or their expression in vivo. In contrast, a histone methyltransferase inhibitor selectively promotes SINE expression and occupancy by RNA polymerase III. The data suggest that methylation of histones rather than DNA plays a dominant role in suppressing SINE transcription.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms7569

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SINEs provide binding sites for MBPs. (a) Semiquantitative ChIP assay in HeLa cells showing the binding of MBD1, MBD2 and MeCP2 at Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E loci. Alu19J is also from chromosome 19. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock sample. (b) Mean±s.e.m. of the percentage input bound in two independent ChIP–quantitative PCR assays with HeLa cells and antibodies against histone H3, TAFI48, MBD1, MBD2 and MeCP2, as indicated. No antibody was used for the mock samples. Amplifications were carried out using primers for the Apo-E and 7SL genes, Alu PV subfamily consensus sequence and individual Alus on chromosomes 6, 10, 19 and 22, as indicated. (c) Semiquantitative ChIP assay in A31 fibroblasts showing binding of MBD1, MBD2 and MeCP2 at B1 and B2 loci, as well as 7SL and Apo-E genes. B1 and B2 consensus primers match ~102 members of the B1 and B2 families, whereas B1(c9) and B2(c9) primers detect unique loci on chromosome 9. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively.
Figure 1 SINEs provide binding sites for MBPs. (a) Semiquantitative ChIP assay in HeLa cells showing the binding of MBD1, MBD2 and MeCP2 at Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E loci. Alu19J is also from chromosome 19. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock sample. (b) Mean±s.e.m. of the percentage input bound in two independent ChIP–quantitative PCR assays with HeLa cells and antibodies against histone H3, TAFI48, MBD1, MBD2 and MeCP2, as indicated. No antibody was used for the mock samples. Amplifications were carried out using primers for the Apo-E and 7SL genes, Alu PV subfamily consensus sequence and individual Alus on chromosomes 6, 10, 19 and 22, as indicated. (c) Semiquantitative ChIP assay in A31 fibroblasts showing binding of MBD1, MBD2 and MeCP2 at B1 and B2 loci, as well as 7SL and Apo-E genes. B1 and B2 consensus primers match ~102 members of the B1 and B2 families, whereas B1(c9) and B2(c9) primers detect unique loci on chromosome 9. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively.CC BY · PubMed Central
Figure 2 Pol III co-occupies methylated SINEs with MBPs. (a) Semiquantitative ChIP assay in A31 fibroblasts showing specific binding of TFIIIB, TFIIIC and pol III to B1 and B2 loci, as well as 7SL, but not the Apo-E gene. Histone H3 and TAFI48 provide positive and negative controls, respectively. (b) Semiquantitative ChIP assay in HeLa cells showing occupancy of pol III, TFIIIB and TFIIIC at Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E genes. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock sample. (c) Mean±s.e.m. of the percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays in HeLa cells, of the indicated proteins at individual Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E loci and Alu PV subfamily consensus. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock samples. P values are calculated by t-test. (d) Mean±s.e.m. of four independent sequential ChIP–qPCR assays in which DNA immunoprecipitated from HeLa cells using pol III antibody was reprecipitated using antibodies against pol III, TFIIIB, TAFI48 (negative control), MBD1, MBD2 and MeCP2, as indicated. No TAFI48 signal was detected on Alu(c6).
Figure 2 Pol III co-occupies methylated SINEs with MBPs. (a) Semiquantitative ChIP assay in A31 fibroblasts showing specific binding of TFIIIB, TFIIIC and pol III to B1 and B2 loci, as well as 7SL, but not the Apo-E gene. Histone H3 and TAFI48 provide positive and negative controls, respectively. (b) Semiquantitative ChIP assay in HeLa cells showing occupancy of pol III, TFIIIB and TFIIIC at Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E genes. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock sample. (c) Mean±s.e.m. of the percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays in HeLa cells, of the indicated proteins at individual Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E loci and Alu PV subfamily consensus. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock samples. P values are calculated by t-test. (d) Mean±s.e.m. of four independent sequential ChIP–qPCR assays in which DNA immunoprecipitated from HeLa cells using pol III antibody was reprecipitated using antibodies against pol III, TFIIIB, TAFI48 (negative control), MBD1, MBD2 and MeCP2, as indicated. No TAFI48 signal was detected on Alu(c6).CC BY · PubMed Central
Figure 3 Genome-wide methylation analysis of pol III-bound Alu DNA. (a) Comparison of the fraction of methylation of the indicated Alu subfamilies between genomic DNA (input) and pol III-bound DNA, as determined by ChIP-BS-Seq. The height of a vertical line indicates the fraction methylated at a particular C within the subfamily consensus sequence. (b) Genome-wide comparison of pol III occupancy and DNA methylation of Alu subfamilies. (c) Comparison of the extent of methylation of the AluYa5 subfamily between genomic DNA (input) and pol III-bound DNA. The height of a vertical line indicates the fraction methylated at a particular C within the subfamily consensus sequence. A- and B-block promoter elements are indicated. (d) Pol III occupancy plotted against DNA methylation for Alu SINEs (blue) and tRNA genes (red). Data are plotted as a moving average with 25 data points per window.
Figure 3 Genome-wide methylation analysis of pol III-bound Alu DNA. (a) Comparison of the fraction of methylation of the indicated Alu subfamilies between genomic DNA (input) and pol III-bound DNA, as determined by ChIP-BS-Seq. The height of a vertical line indicates the fraction methylated at a particular C within the subfamily consensus sequence. (b) Genome-wide comparison of pol III occupancy and DNA methylation of Alu subfamilies. (c) Comparison of the extent of methylation of the AluYa5 subfamily between genomic DNA (input) and pol III-bound DNA. The height of a vertical line indicates the fraction methylated at a particular C within the subfamily consensus sequence. A- and B-block promoter elements are indicated. (d) Pol III occupancy plotted against DNA methylation for Alu SINEs (blue) and tRNA genes (red). Data are plotted as a moving average with 25 data points per window.CC BY · PubMed Central
Figure 4 DNA methylation does not prevent pol III occupancy of SINEs. (a) Percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays with mouse ES cells treated for 16 h with (+) or without (−) 5-azacytidine, showing occupancy of MBD2, MeCP2 and pol III at 7SL, B1 and B2 loci, as well as an Alu inserted onto chromosomes 14 and 17. ChIPs for TAFI48 and without antibody (mock) provide negative controls. (b) Percentage input bound in three independent ChIP–qPCR assays with HeLa cells treated for 72 h with (+) or without (−) 5-azacytidine, showing the binding of MBD2, TFIIIB, TFIIIC and pol III to DNA centred over the body of Alu(c22) or 200 bp downstream. The resolution of this assay is limited by the size of the genomic DNA fragments (~500 bp). (c) Percentage input bound in two independent ChIP–qPCR assays with matched Dnmt1+/+ and Dnmt1−/− fibroblasts showing occupancy of MBD2, TFIIIB, TFIIIC and pol III at B1 and B2 loci, as well as 7SL and Apo-E genes. ChIPs for TAFI48 and without antibody (mock) provide negative controls. Error bars indicate s.e.m. and all P values are calculated by t-test.
Figure 4 DNA methylation does not prevent pol III occupancy of SINEs. (a) Percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays with mouse ES cells treated for 16 h with (+) or without (−) 5-azacytidine, showing occupancy of MBD2, MeCP2 and pol III at 7SL, B1 and B2 loci, as well as an Alu inserted onto chromosomes 14 and 17. ChIPs for TAFI48 and without antibody (mock) provide negative controls. (b) Percentage input bound in three independent ChIP–qPCR assays with HeLa cells treated for 72 h with (+) or without (−) 5-azacytidine, showing the binding of MBD2, TFIIIB, TFIIIC and pol III to DNA centred over the body of Alu(c22) or 200 bp downstream. The resolution of this assay is limited by the size of the genomic DNA fragments (~500 bp). (c) Percentage input bound in two independent ChIP–qPCR assays with matched Dnmt1+/+ and Dnmt1−/− fibroblasts showing occupancy of MBD2, TFIIIB, TFIIIC and pol III at B1 and B2 loci, as well as 7SL and Apo-E genes. ChIPs for TAFI48 and without antibody (mock) provide negative controls. Error bars indicate s.e.m. and all P values are calculated by t-test.CC BY · PubMed Central
Figure 5 SINE expression is not stimulated by loss of DNA methylation. (a) Analysis by semiquantitative RT–PCR of expression levels of the indicated transcripts in matched Dnmt1+/+ and Dnmt1−/− fibroblasts. Duplicate samples are shown for both cell types. Apo-E and p53BP2 mRNAs provide controls that have been documented as being suppressed by DNA methylation. GAPDH mRNA provides a loading control. (b) Analysis by semiquantitative RT–PCR of expression levels of the indicated transcripts in mouse ES cells treated for 16 h with (+) or without (−) 5-azacytidine. Apo-E mRNA provides a control that has been documented as being inhibited by DNA methylation. ARPP P0 mRNA provides a loading control. (c) Analysis by semiquantitative RT–PCR of expression levels of the indicated transcripts in HeLa cells treated for 72 h with 5-azacytidine. Apo-E mRNA provides a control that has been documented as being inhibited by DNA methylation. ARPP P0 mRNA provides a loading control. (d) Analysis by primer extension of Alu transcripts in the RNA from Fig. 5c. Bracket indicates ~240 bp products that initiate at the principle pol III start site of Alu. Reverse transcriptase was omitted from the reactions in lanes 1 and 2. To confirm that the assay was not saturated, raising the amount of template RNA from 5 (lanes 5 and 6) to 10 μg (lanes 3 and 4) is shown to give a stronger signal. Alu, B1 and B2 RT–PCRs were performed with Alu, B1 and B2 consensus primers, respectively (Supplementary Table 1).
Figure 5 SINE expression is not stimulated by loss of DNA methylation. (a) Analysis by semiquantitative RT–PCR of expression levels of the indicated transcripts in matched Dnmt1+/+ and Dnmt1−/− fibroblasts. Duplicate samples are shown for both cell types. Apo-E and p53BP2 mRNAs provide controls that have been documented as being suppressed by DNA methylation. GAPDH mRNA provides a loading control. (b) Analysis by semiquantitative RT–PCR of expression levels of the indicated transcripts in mouse ES cells treated for 16 h with (+) or without (−) 5-azacytidine. Apo-E mRNA provides a control that has been documented as being inhibited by DNA methylation. ARPP P0 mRNA provides a loading control. (c) Analysis by semiquantitative RT–PCR of expression levels of the indicated transcripts in HeLa cells treated for 72 h with 5-azacytidine. Apo-E mRNA provides a control that has been documented as being inhibited by DNA methylation. ARPP P0 mRNA provides a loading control. (d) Analysis by primer extension of Alu transcripts in the RNA from Fig. 5c. Bracket indicates ~240 bp products that initiate at the principle pol III start site of Alu. Reverse transcriptase was omitted from the reactions in lanes 1 and 2. To confirm that the assay was not saturated, raising the amount of template RNA from 5 (lanes 5 and 6) to 10 μg (lanes 3 and 4) is shown to give a stronger signal. Alu, B1 and B2 RT–PCRs were performed with Alu, B1 and B2 consensus primers, respectively (Supplementary Table 1).CC BY · PubMed Central
Figure 6 SUV39H1 inhibits pol III loading and expression of some SINEs. (a) Mean±s.e.m. of the percentage input bound in two independent ChIP–quantitative PCR (qPCR) assays with HeLa cells, showing occupancy of H3, TAFI48, H3K9me3, SUV39H1 and HP1 at Alu loci, 7SL and p21 (positive control) genes. (b) Mean±s.e.m. of the percentage input bound in two independent ChIP–qPCR assays with HeLa cells treated for 24 h with vehicle (−) or 100 nM chaetocin (+), showing occupancy of H3, TAFI48, H3K9me3, pol III and TFIIIC at Alu loci, 7SL and Apo-E genes. (c) Semiquantitative RT–PCR analysis of expression levels of indicated transcripts in HeLa cells treated for 24 h with indicated concentrations of chaetocin. (d) Analysis by primer extension of expression levels of Alu transcripts initiated from pol III start site in HeLa cells treated for 24 h with indicated concentrations of chaetocin. Reverse transcriptase was omitted from reactions in lanes 5–8. Right panel shows mean±s.d. of fold change in Alu expression in two independent experiments quantified using ImageJ. All P values are calculated by t-test.
Figure 6 SUV39H1 inhibits pol III loading and expression of some SINEs. (a) Mean±s.e.m. of the percentage input bound in two independent ChIP–quantitative PCR (qPCR) assays with HeLa cells, showing occupancy of H3, TAFI48, H3K9me3, SUV39H1 and HP1 at Alu loci, 7SL and p21 (positive control) genes. (b) Mean±s.e.m. of the percentage input bound in two independent ChIP–qPCR assays with HeLa cells treated for 24 h with vehicle (−) or 100 nM chaetocin (+), showing occupancy of H3, TAFI48, H3K9me3, pol III and TFIIIC at Alu loci, 7SL and Apo-E genes. (c) Semiquantitative RT–PCR analysis of expression levels of indicated transcripts in HeLa cells treated for 24 h with indicated concentrations of chaetocin. (d) Analysis by primer extension of expression levels of Alu transcripts initiated from pol III start site in HeLa cells treated for 24 h with indicated concentrations of chaetocin. Reverse transcriptase was omitted from reactions in lanes 5–8. Right panel shows mean±s.d. of fold change in Alu expression in two independent experiments quantified using ImageJ. All P values are calculated by t-test.CC BY · PubMed Central
Figure 7 SINE repression by H3K9Me3 does not require DNA methylation. (a) Percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays with Dnmt1−/− fibroblasts assessing binding of TAFI48, H3K9me3, MBD2 and pol III at 7SL, B1, B2 and Apo-E loci. H3K9me3 data were normalized against total H3. For clarity, Fig. 7a displays a subset of the data shown in Fig. 7c. (b) Percentage input bound in two independent ChIP–qPCR assays of ES cells treated for 16 h with (+) or without (−) 5-azacytidine, assessing binding of TAFI48, MBD2, H3K9me3 and pol III at 7SL, B1 and B2 loci, as well as an Alu inserted onto chromosomes 14 and 17. H3K9me3 data were normalized against total H3. (c) Percentage input bound in three independent ChIP–qPCR assays of matched Dnmt1−/− and Dnmt1+/+ fibroblasts treated for 24 h with (+) or without (−) 100 nM chaetocin, assessing binding of TAFI48, H3K9me3, MBD2 and pol III at 7SL, B1 and B2 and Apo-E loci. H3K9me3 data were normalized against total H3. (d) Semiquantitative RT–PCR analysis of expression levels of indicated transcripts in matched Dnmt1+/+ and Dnmt1−/− fibroblasts treated for 24 h with indicated concentrations of chaetocin. Error bars indicate s.e.m. and all P values are calculated by t-test.
Figure 7 SINE repression by H3K9Me3 does not require DNA methylation. (a) Percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays with Dnmt1−/− fibroblasts assessing binding of TAFI48, H3K9me3, MBD2 and pol III at 7SL, B1, B2 and Apo-E loci. H3K9me3 data were normalized against total H3. For clarity, Fig. 7a displays a subset of the data shown in Fig. 7c. (b) Percentage input bound in two independent ChIP–qPCR assays of ES cells treated for 16 h with (+) or without (−) 5-azacytidine, assessing binding of TAFI48, MBD2, H3K9me3 and pol III at 7SL, B1 and B2 loci, as well as an Alu inserted onto chromosomes 14 and 17. H3K9me3 data were normalized against total H3. (c) Percentage input bound in three independent ChIP–qPCR assays of matched Dnmt1−/− and Dnmt1+/+ fibroblasts treated for 24 h with (+) or without (−) 100 nM chaetocin, assessing binding of TAFI48, H3K9me3, MBD2 and pol III at 7SL, B1 and B2 and Apo-E loci. H3K9me3 data were normalized against total H3. (d) Semiquantitative RT–PCR analysis of expression levels of indicated transcripts in matched Dnmt1+/+ and Dnmt1−/− fibroblasts treated for 24 h with indicated concentrations of chaetocin. Error bars indicate s.e.m. and all P values are calculated by t-test.CC BY · PubMed Central
Figure 8 5-azacytidine stimulates translocation between Alus. (a) Schematic illustration of system used to induce and detect chromosomal translocations at Alu elements. (b) Mean±s.d. from three independent experiments measuring the relative incidence of translocation between Alu elements located on chromosomes 14 and 17 in ES cells treated with 5-azacytidine or bleomycin, relative to cells without drug. P values are calculated by t-test.
Figure 8 5-azacytidine stimulates translocation between Alus. (a) Schematic illustration of system used to induce and detect chromosomal translocations at Alu elements. (b) Mean±s.d. from three independent experiments measuring the relative incidence of translocation between Alu elements located on chromosomes 14 and 17 in ES cells treated with 5-azacytidine or bleomycin, relative to cells without drug. P values are calculated by t-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 63 references

Cited by

See all 105

Metadata

Authors
Varshney, D., Vavrova-Anderson, J., Oler, A. J., Cowling, V. H., Cairns, B. R., & White, R. J.
Affiliations
  • University of Dundee (GB)
  • University of Glasgow (GB)
  • Howard Hughes Medical Institute (US)
  • University of York (GB)
Corresponding author
  • Varshney, Dhaval
  • White, Robert J.
Venue
Nature Communications
Published
2015-03-23
Volume
6
Issue
1
Pages
6569-6569
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1995229781
Cited by
105
References
63
Citations by year
2026: 5 · 2025: 3 · 2024: 22 · 2023: 7 · 2022: 7 · 2021: 13 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 16 · 2016: 11 · 2015: 3
FWCI
15.33
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Wellcome Trust (073424, 097945)
  • Huntsman Cancer Institute
  • Cancer Research UK
  • Medical Research Council (MR/K024213/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
short interspersed nuclear elements, Alu elements, RNA polymerase III, histone methylation, DNA methylation, retrotransposition, histone methyltransferase inhibitors, chromatin accessibility, insertional mutagenesis, chromosomal rearrangements
MeSH terms
Animals, DNA-Binding Proteins, Fibroblasts, HeLa Cells, Histones, Humans, Methylation, RNA Polymerase III, Transcription Factors, Transcription, Genetic, DNA Methylation, Short Interspersed Nucleotide Elements, Alu Elements, Histone Code, Chromatin Immunoprecipitation, Mice, Methyl-CpG-Binding Protein 2, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SINE transcription by RNA polymerase III is suppressed by histone methylation but not by DNA methylation. https://app.cochat.ai/papers/10.1038/ncomms7569
The paper
Varshney, D., Vavrova-Anderson, J., Oler, A. J., Cowling, V. H., Cairns, B. R., & White, R. J. (2015). SINE transcription by RNA polymerase III is suppressed by histone methylation but not by DNA methylation. Nature Communications. https://doi.org/10.1038/ncomms7569

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.